Cystic Fibrosis Foundation: Research Grants

The Cystic Fibrosis Foundation offers Research Grants aimed at enhancing the understanding of cystic fibrosis pathogenesis. These grants support projects exploring airway defense, microbial adaptation, and disease manifestations. Proposals should be hypothesis-driven with preliminary data. Funding of up to $150,000 per year is available for three years, with the potential for renewal. Priority is given to projects that seek to develop treatment strategies and improve disease comprehension.

NOTE:
Applicants from for-profit organizations should speak to the Program Officer about eligibility before applying through this mechanism.We strongly encourage all applicants pre-register their profile, institution, contacts, and Title of their application at least two weeks prior to the application deadline. This will help to ensure the CFF Grants & Contracts Management and Administration (GCMA) Office is able to assist all applicant with any potential system-related queries prior to the Application Deadline.
The mission of the Cystic Fibrosis Foundation is to cure cystic fibrosis and to provide all people with CF the opportunity to lead long, fulfilling lives by funding research and drug development, partnering with the CF community, and advancing high-quality, specialized care.
Research Grants are intended to support efforts that will improve our understanding of disease pathogenesis, such as defects in airway defense, microbial adaption to the CF lung, mucociliary clearance and airway hydration, and extrapulmonary manifestations of the disease.
Proposals must be hypothesis driven and contain sufficient preliminary data to justify support from the CF Foundation. Proposals that aim to develop tools or reagents that will facilitate research may be considered through this mechanism. Information derived from such studies will hopefully lead to submission to other funding agencies, such as the National Institutes of Health (NIH).
Funding
Support is available for $150,000 per year (plus 12% for indirect costs) for up to three years, at which time a grant may be competitively renewed for additional funding.